Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor.

Autor: Chasse MH; Van Andel Research Institute, Grand Rapids, MI, USA., Johnson BK; Van Andel Research Institute, Grand Rapids, MI, USA., Boguslawski EA; Van Andel Research Institute, Grand Rapids, MI, USA., Sorensen KM; Van Andel Research Institute, Grand Rapids, MI, USA., Rosien JE; Dartmouth College, Hanover, NH, USA., Kang MH; Texas Tech University Health Sciences Center, Lubbock, TX, USA., Reynolds CP; Texas Tech University Health Sciences Center, Lubbock, TX, USA., Heo L; Van Andel Research Institute, Grand Rapids, MI, USA., Madaj ZB; Van Andel Research Institute, Grand Rapids, MI, USA., Beddows I; Van Andel Research Institute, Grand Rapids, MI, USA., Foxa GE; Van Andel Research Institute, Grand Rapids, MI, USA., Kitchen-Goosen SM; Van Andel Research Institute, Grand Rapids, MI, USA., Williams BO; Van Andel Research Institute, Grand Rapids, MI, USA., Triche TJ Jr; Van Andel Research Institute, Grand Rapids, MI, USA., Grohar PJ; Van Andel Research Institute, Grand Rapids, MI, USA.; The Children's Hospital of Philadelphia, Philadelphia, PA, USA.; University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.

Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2021 Feb 05; Vol. 13 (2), pp. e12640. Date of Electronic Publication: 2020 Dec 17.